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Abstract—Dynamic imaging with positron emission tomog-
raphy (PET) is widely used for the in vivo measurement of
regional cerebral metabolic rate for glucose (rCMRGlc) with
[18F]fluorodeoxy-D-glucose (FDG) and is used for the clinical
evaluation of neurological disease. However, in addition to the
acquisition of dynamic images, continuous arterial blood sampling
is the conventional method to obtain the tracer time-activity curve
in blood (or plasma) for the numeric estimation of rCMRGlc in
mg glucose/100-g tissue/min. The insertion of arterial lines and the
subsequent collection and processing of multiple blood samples
are impractical for clinical PET studies because it is invasive, has
the remote, but real potential for producing limb ischemia, and
it exposes personnel to additional radiation and risks associated
with handling blood. In this paper, based on our previously
proposed method for extracting kinetic parameters from dynamic
PET images, we developed a modified version (post-estimation
method) to improve the numerical identifiability of the parameter
estimates when we deal with data obtained from clinical studies.
We applied both methods to dynamic neurologic FDG PET studies
in three adults. We found that the input function and parameter
estimates obtained with our noninvasive methods agreed well with
those estimated from the gold standard method of arterial blood
sampling and that rCMRGlc estimates were highly correlated
( = 0 973). More importantly, no significant difference was
found between rCMRGlc estimated by our methods and the gold
standard method ( 0 16). We suggest that our proposed
noninvasive methods may offer an advance over existing methods.
Index Terms—Arterial input function, cerebral glucose metab-
olism, dynamic imaging, [18F]fluorodeoxy-D-glucose, noninvasive
measurement, positron emission tomography.
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I. INTRODUCTION
POSITRON emission tomography (PET) with [ F]fluoro-deoxy-D-glucose (FDG) has been widely used to study
regional brain glucose metabolism in normal subjects and
in patients with a variety of neurological conditions. The
three-compartment tracer kinetic model was originally de-
veloped by Sokoloff et al. [1] to measure glucose metabolic
rate in the albino rat and it was later validated in humans
[2]–[4]. A drawback of this approach is measurement of the
input function for the compartment model. The input function
is generally obtained by sampling blood at the radial artery
or from an arterialized vein in a hand [2]–[4]. Arterial blood
sampling is not practicable in a clinical environment because
it is invasive and has the potential for causing irreversible
tissue ischemia. Further, it may not be tolerated by the patient
if additional studies are required for longitudinal evaluation.
It also exposes personnel who perform the blood sampling
to additional radiation and the risks associated with handling
patient blood [5].
Recently, effort has been directed toward reducing or obvi-
ating the need for arterial blood sampling. The arterialized–ve-
nous (a–v) method involves heating the hand in a hot water bath
which then promotes shunting between the capillary and ve-
nous vascular bed to avoid the discomfort and risks associated
with arterial cannulation [3]. However, this method requires pro-
longed hand warming to ensure adequate shunting, and it is very
dependent upon the site chosen for the placement of the venous
cannula and the rate of blood flow. The best results are usually
obtained from a cannula that is placed in a large vein on the
dorsum of the hand, typically in a muscular male. Furthermore,
it does not avoid the need for frequent sampling. Phillips et al.
reported a method that uses a limited number of arterial blood
samples [6], however, their method relies on arterial catheteri-
zation. Takikawa et al. proposed a method that approximates the
input function by the average obtained from a population sample
of humans [7], but arterial (or a–v) sampling is still necessary
for the determination of the population input function. Eberl et
al. reported a similar approach to Takikawa et al., but they ob-
tained blood samples using an a–v approach [8]. The input func-
tion for an individual patient was scaled by calibrating a “stan-
dard” input curve with blood samples drawn at 10- and 45-min
postinjection. These methods simplify the generation of quan-
titative data for neurological FDG PET studies, but they do not
directly measure the input function in an individual, nor do they
allow the estimation of the microparameters (rate constants) of
1089–7771/01$10.00 © 2001 IEEE
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TABLE I
BRAIN STRUCTURES AND TISSUE TYPES USED FOR ROI ANALYSIS
*denotes the ROIs used for modeling with SIME
the FDG model. Furthermore, all these approaches would re-
quire repeated measurements in a group of patients or volun-
teers each time a new tracer or different infusion rate is used.
A technique that was not invasive, practical to implement, and
accurate would have advantages for the routine measurement of
cerebral glucose metabolism in the clinic.
We recently proposed a modeling approach that estimates the
input function and determines the physiological parameters si-
multaneously from several tissue time-activity curves (TACs).
We evaluated this technique in computer simulations [9]. How-
ever, this method has not yet been tested in clinical studies. In
this paper, we report our preliminary data with this method in
dynamic neurologic FDG PET studies in three adults and pro-
pose a modified method (post-estimation method), which im-
proves the standard deviation (SD) of parameter estimates. We
also compare these two methods to the gold standard method in
which continuous arterial blood samples are taken.
II. MATERIALS AND METHODS
A. Human Studies
Dynamic FDG PET studies were performed on three human
subjects. One had refractory epilepsy and two were normal
volunteers. All studies were performed at the National PET/Cy-
clotron Center, Taipei Veterans General Hospital, Taiwan,
R.O.C. The studies were approved by the Institution Review
Board. The PET scans were performed with a PC4096-15WB
PET tomograph (GE/Scan-ditronix) that has eight rings and
provides 15 slices with axial and transaxial resolutions of
6.5-mm full width at half maximum (FWHM) in the center
of the field of view (FOV). The subjects fasted overnight
before the study. A 15-min transmission scan was performed
using rotating rod sources of Ge for attenuation correction
prior to intravenous administration of approximately 370 MBq
FDG. The PET studies were performed for 2-h post injection.
However, for the purpose of this study, only the first 60 min of
data were used since this is a more practical and commonly em-
ployed protocol in other PET centers. During the first 60 min,
18 arterial blood samples were collected every 15-s from 0-
to 2-min post injection; every 30-s from 2 to 3.5 min; and at
7, 10, 15, 20, 30, and 60 min. The samples were immediately
placed on ice and the plasma was subsequently separated for
the determination of FDG and glucose concentrations. The
scanning schedule for the dynamic FDG PET studies during
the first 60 min was: ten 12-s scans, two 30-s scans, two
1-min scans, one 1.5-min scan, one 3.5-min scan, two 5-min
scans, one 10-min scan, and one 30-min scan. The acquired
PET data were also decay corrected to the time of injection.
The tomographic images were reconstructed using filtered
back-projection with a Hann filter (cutoff frequency of
the Nyquist frequency). Fifteen regions of interest (ROIs) of
irregular shape and size were manually drawn over the PET
images to obtain the tissue TACs for each subject. Table I
tabulates the names and abbreviations of the brain structures
and tissue types selected for the ROIs. The ROIs selected for
modeling with the proposed method were based on visual
identification of their corresponding TACs [9].
B. FDG Model
The differential equations that describe the FDG three-com-




where , , and represent FDG concentration in
the plasma, FDG concentration in the tissue, and FDG-6-phos-
phate (FDG-6-P) concentration in the tissue, respectively. The
rate constants in the model are (min ) for forward transport
of the FDG to tissue, (min ) for reverse transport of FDG
from the tissue to plasma, (min ) for phosphorylation of
FDG to FDG-6-P in tissue and (min ) for dephosphoryla-
tion of FDG-6-P to FDG in tissue. The actual tissue activity
measured by PET can be expressed as
(4)
where is the total tissue activity, and CBV (mL/100 g or
%vol) is the fractional cerebral blood volume, which accounts
for the vascular contribution in the tissue ROI [10], [11]. The
regional cerebral metabolic rate for glucose (rCMRGlc) is cal-
culated according to the following equation [3], [4]:
(5)
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Fig. 1. Comparison of the conventional kinetic approach and the proposed noninvasive method. The conventional approach requires to utilize TACs in plasma
and tissue. On the other hand, the proposed method requires the tissue TACs in two or more regions.
where is the glucose concentration in plasma, and is
the lumped constant that embodies the difference between FDG
and glucose in transportation and phosphorylation [3], [4]. The
macro-parameter is proportional to rCM-
RGlc and to the uptake of FDG. In this paper, rCMRGlc (or,
equivalently, ) is one of the main parameters used to evaluate
the accuracy of our proposed method.
C. Conventional Kinetic Method
In the conventional kinetic approach, the rate constants in the
kinetic model are determined by nonlinear least squares (NLLS)
fitting to the tissue TAC [4]. The model differential equations
(2) and (3) are solved and a convolution integral equation that
represents the tissue TAC is formulated [3], [4]. NLLS is then
employed to minimize the errors between the convolution inte-
gral equation and the observed PET measurements. Note that the
formulation of the convolution integral equation requires knowl-
edge of the input function , which is obtained by continu-
ously measuring the arterial or a–v blood samples.
D. Noninvasive Approach
We have previously reported [9] the identifiability, reliability,
and Monte Carlo simulations of our proposed method and only
a brief summary of the method is presented here. Multiple tissue
TACs can be obtained by defining different ROIs on the dynamic
PET images (shown in Fig. 1). These TACs are the convolution
of the input function with the physiological impulse response
functions (IRFs) corresponding to the ROIs. The input function
and the IRF parameters may thus be estimated simultaneously
from two or more tissue TACs. We refer to this method as si-
multaneous estimation (SIME).
The input function and physiological parameters of the IRFs
were derived by the conventional kinetic approach and SIME. A
input function model for bolus administration of FDG [12] was
used in SIME to describe the (estimated) arterial input function
and to reduce the uncertainties in parameter estimates [13], [14].
The mathematical expression for this model without the delay
factor is given by
(6)
where (in Ci/mL/min), and (in Ci/mL) are the co-
efficients of the model; , and (in min ) are the eigen-
values of the model. These parameters are determined by least
squares fitting the blood samples in the conventional kinetic
method and SIME.
In the input function, the last exponential described by the pa-
rameters and in (6) dominates the tail of the blood curve.
We have shown in our computer simulation study that using two
late venous samples as the a priori knowledge for the input func-
tion can markedly improve the identifiability and reliability of
SIME [9]. In this paper, a similar strategy was adopted. How-
ever, instead of fixing and to certain assumed values, as
we did in our simulation [9], two venous blood samples (30- and
60-min postinjection) were taken to determine and .
Having defined the last exponential of the input function and
the ROIs whose TACs were used for modeling, NLLS was used
in SIME to determine the input function and the IRF parameters
by minimizing the following cost function:
(7)
where is the total number of ROIs incorporated into the model
fitting procedure, is the number of frames for each tissue
TAC, is the IRF of the th ROI with microparameters
and CBV, denotes the vector of parameters to be es-
timated and it is formed by concatenating several sets of rate
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constant parameters , , , , CBV in different ROIs
with the parameter vector , , , , , of the
input function, is a Dirac delta function shifted in time
by units, is the convolution integral operator, is the
estimated arterial input function, is the FDG concentra-
tion in plasma measured at time , is the
number of venous blood samples taken late in the course of the
study, and is chosen to be 100 so that the samples from the
blood [i.e. ] are given more weight, as they are usually
less noisy (thus, more reliable) than PET measurements. In all
of the studies, were measured by counting the radioac-
tivity concentrations in the venous blood samples ( ) taken
at 30- and 60-min postinjection in an NaI well counter that was
cross-calibrated to the PET scanner.
E. Post-Estimation Technique
Although precise parameter estimates can be obtained theo-
retically with SIME, raw PET data are often extremely noisy
due to issues such as photon attenuation, scatter, etc. The re-
sult is that the information matrix becomes poorly conditioned
and the subsequent estimation of the SDs of the parameter esti-
mates are poor. In addition, input/output scaling can also result
in large SDs in the parameters because sensitivities of the input
and output are not of the same order, which can produce near
rank deficiency in the information matrix. The dimensions and
the nonlinearity of parameter space can also affect the informa-
tion matrix to a certain extent. In this situation, SIME may not
be able to provide acceptable estimates of the SDs, though the
values of the parameter estimates are accurate. Thus, we have
introduced a technique that is applied after SIME, for situations
where the parameter estimates have large SDs or coefficients
of variation (CVs). We refer to this method as simultaneous es-
timation with post-estimation (SIMEP), which is based on the
assumption that the input function obtained by SIME can glob-
ally minimize the errors between all of the measured data and
the predicted tissue TACs by (7) in the least squares sense. The
parameters in the IRFs can then be estimated separately by using
the estimated input function and the individual tissue TACs as
input–output pairs. The SDs of the parameters can be greatly
improved due to the reduction in dimensionality of parameter
space.
F. Data Analysis
The recovered (or estimated) input function obtained from
SIME was compared to the measured arterial input function vi-
sually to see if there was any discrepancy. The areas under the
measured and recovered input functions (AUCs) for the time
from 0 to 2 min (where the peak occurs), for the time from 2 to
10 min (rapid washout), for the time from 10 to 30 min (slow
washout), and for the time from 30 to 60 min (constant clear-
ance), were computed using the trapezoidal method and com-
pared. Compartmental model fitting with the use of the mea-
sured arterial blood samples as the input function (i.e., gold stan-
dard method) and with the use of the input function recovered by
SIME (i.e., SIMEP) were then performed on the ten ROIs, which
were not used in SIME and the corresponding rCMRGlc in each
ROI was then estimated. Linear regression analysis was carried
Fig. 2. Comparison of the measured arterial input function with the recovered
input function for one subject. The recovered blood curve was obtained from
simultaneously fitting three ROI TACs at a time.
out to compare the estimates of rCMRGlc obtained from both
methods for the ten ROIs tabulated in Table I for all subjects.
Paired student’s test was performed on the 30 (three subjects
ten ROIs) rCMRGlc estimates to test the hypothesis that rCM-
RGlc estimates obtained from the invasive and SIMEP methods
are not significantly different, and was chosen as the
significance level.
For the tissue TACs that were used in SIME, we mainly
looked at the parameter estimates and the SDs in the IRFs
obtained with the invasive method, SIME, and SIMEP, respec-
tively, to evaluate the identifiability and the reliability of SIME
and to verify that more reliable results can be obtained with
SIMEP. The SDs for the rate constants were the asymptotic
SDs, which were given by the square roots of the diagonal
elements of the asymptotic variance–covariance matrix (inverse
of the Fisher Information matrix) of NLLS, while the precision
of rCMRGlc was calculated by error propagation of the rate
constants.
III. RESULTS
A. Recovery of the Input Functions
Fig. 2 shows the measured and recovered input functions in
one of the studies. The recovered blood curve was derived by
minimizing the cost function with the tissue TACs obtained
from three ROIs [grey matter (GM), white matter (WM), and
whole brain (WB)]. It can be seen that there was very good
agreement between the recovered and measured arterial blood
curves. The difference between the two curves at the peak was
only 2.5%. It was also found that the time at which the two input
functions reach their peaks was almost identical. Similar results
were obtained for all studies where the number of ROIs was
more than two. However, in some cases, the peak estimation
could be higher for the recovered input function. An example
is shown in Fig. 3, where the result was obtained from another
subject studied. The tissue TACs were also obtained from three
ROIs (GM, WM, and WB). It is, however, important to note
that the measured arterial input function may not necessarily
be very accurate due to measurement noise.
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Fig. 3. Comparison of the measured arterial input function with the recovered
input function for another subject studied. Again, the recovered blood curve
was obtained from simultaneously fitting three ROI TACs at a time. However,
the peak estimation was not as good as the one shown in Fig. 2.
Table II compares the AUCs of the measured arterial input
functions and the recovered input functions at different time in-
tervals of the experiment with different number of ROIs used in
SIME. It can be seen that the areas covered by the measured ar-
terial input functions and the recovered input functions for the
period beyond 0–2 min were in very good agreement, despite
the possible underestimation or overestimation within 0–2 min
where peak occurs, due to underestimation or overestimation
of the peaks. In general, the recovered input functions resem-
bled their true measurements very well. Moreover, the ability
of SIME to recover the input function was generally improved
with increasing number of ROIs, as seen in Table II, provided
that the tissue TACs used for modeling in SIME are distinct.
B. Estimation of the Physiological Parameters
Apart from the recovery of the arterial input function from
the measured tissue TACs, the estimation of the physiological
parameters and the rate constants are also of primary concern.
Fig. 4 plots the measured tissue data (at mid-scan time) and the
fitted curves by SIME, SIMEP, and the conventional kinetic (in-
vasive) method, respectively. The results shown for SIME were
obtained from fitting two ROIs (GM and WM) according to
the cost function [see (7)]. It can be seen that the fitted curves
were in good agreement with the measured data. Furthermore,
the TACs predicted by the parameters obtained from SIME and
SIMEP are almost identical, indicating that the main difference
between SIME and SIMEP is in the parameter variances rather
than the values themselves. Similar results were also found for
all subjects with different number of ROIs included in the fitting
procedure of SIME.
Figs. 5 and 6 plot the parameter estimates and the SDs
(denoted by error bars) obtained with SIME, SIMEP, and the
invasive method for the IRFs corresponding to the tissue types
of GM and WM, respectively, in one of the subjects. As shown
in the figures, we can obtain quite good estimates of rCMRGlc
for GM and WM when compared to those estimated from
the conventional kinetic method, even when only two ROIs
are used in the model fitting procedure with SIME. However,
TABLE II
COMPARISON OF THE AREAS UNDER THE MEASURED AND RECOVERED INPUT
FUNCTIONS (AUCs) FOR DIFFERENT TIME INTERVALS OF THE EXPERIMENT.
VALUES APPEARING IN BOLD CORRESPOND TO THE AUCs COVERED BY THE
MEASURED ARTERIAL BLOOD CURVES IN THE SUBJECTS
Fig. 4. Arterial blood samples, recovered input function, and predicted tissue
TACs corresponding to GM and WM, respectively. The recovered input function
was obtained by SIME using the TACs of the two tissue types mentioned above.
The fitted curves for the tissue TACs were obtained with the conventional kinetic
method using the arterial blood samples as the input function, with the recovered
input function obtained with SIME and SIMEP, respectively
there was a poor estimation of SDs by SIME for some of the
parameters in the IRFs, e.g., and CBV. In addition, the
estimated SDs obtained with SIME for the parameters may be
very large [(standard deviation) (parameter estimate) , or
equivalently, percent CV ], as shown in the figures,
in which some of the error bars are extended beyond the
maximum values of the graphs. When SIMEP is applied to
these data, the values and SDs of the estimated parameters are
generally improved as compared to those estimated by SIME
and are comparable to those obtained with the conventional
kinetic method.
Table III shows the comparison of CVs (in percentage) for
rCMRGlc estimates in ten ROIs, obtained with the measured
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Fig. 5. Parameter estimates obtained with SIME, SIMEP, and the conventional kinetic method in GM. (a) k (min ). (b) k (min ). (c) k (min ). (d)
k (min ). (e) CBV (mL/100 g). (f) rCMRGlc (mg/min/100 mL). In (a)–(f), error bars represent the SDs of the parameter estimates.
arterial blood samples as the input function and the recovered
input function obtained with SIME (using three ROIs) for the
three human subjects. The identifiability of the estimates ob-
tained with the measured arterial input functions and the recov-
ered input functions are almost the same. Linear regression anal-
ysis was carried out to compare rCMRGlc estimates obtained
from our methods and from the invasive method. The results are
shown in Fig. 7 where the estimates of rCMRGlc obtained with
the gold standard method were plotted versus those obtained
with SIME (using three ROIs) for different ROIs tabulated in
Table I (excluding those used in SIME) for all subjects. It can
be seen that rCMRGlc can be estimated reliably with the use of
the recovered input functions (SIME, three ROIs). The slope of
the regression line for rCMRGlc was close to one (1.009) and
the intercept was nearly equal to zero (0.007), and there was
very high correlation between the estimates obtained with both
methods ( ). The agreement between
the rCMRGlc estimates was further examined using paired stu-
dent’s test. We found that the estimates obtained with the inva-
sive and the proposed method (SIMEP with the input function
obtained with SIME using three ROIs as an example) were not
significantly different ( , two-tailed test). Similar re-
sults were also found for all subjects with the number of ROIs
included in the fitting procedure of SIME greater than two.
IV. DISCUSSION
Our results show that the proposed methods are able to re-
cover the input function from dynamic PET image data and to
provide good parameter estimates when compared to the con-
ventional kinetic method. The reliability of estimating physio-
logical parameters was improved by our SIMEP method if 2
ROIs were used. Fewer ROIs ( 3) still provided an accurate es-
timation of rCMRGlc, despite the differences between and
CBV estimates and the large variability in the rate constants.
Accurate quantification of rCMRGlc is directly related to the
precise definition of the input function. The shape of the input
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Fig. 6. Parameter estimates obtained with SIME, SIMEP, and the conventional kinetic method in WM. (a) k (min ). (b) k (min ). (c) k (min ). (d)
k (min ). (e) CBV (mL/100 g). (f) rCMRGlc (mg/min/100 mL). In (a)–(f), error bars represent the SDs of the parameter estimates.
TABLE III
COMPARISON OF THE COEFFICIENTS OF VARIATION (IN PERCENTAGE) FOR rCMRGlc ESTIMATES IN TEN ROIs, OBTAINED WITH THE MEASURED ARTERIAL BLOOD
SAMPLES AS THE INPUT FUNCTION AND THE RECOVERED INPUT FUNCTION OBTAINED WITH SIME (USING THREE ROIs) FOR THE THREE HUMAN SUBJECTS
function with its initial shape rising edge followed by a rapid
decline means that the difference between the measured data
and fitted curves could be quite large, although the actual fitting
is extremely good. Therefore, direct comparisons of the differ-
ence between the measured and fitted curves in the early time
may not be the most appropriate means to show the goodness
of fit. In this case, it is better to use the areas covered by the
measured and the recovered input functions for comparison. In
our study, we found that the areas under the estimated and mea-
sured blood curves (AUCs) at different time intervals were gen-
erally in very good agreement. However, the AUCs for the time
interval of 0–2 min were underestimated or overestimated oc-
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Fig. 7. Regression results of the rCMRGlc estimated using the measured
arterial blood samples as the input function (gold standard, but invasive) and
the recovered input function obtained with SIME (using three ROIs) for the
three human subjects. The horizontal axis is the estimated rCMRGlc using the
measured arterial blood samples as the input function (rCMRGlc ), while
the vertical axis is the one using the recovered input function obtained with
SIME (rCMRGlc ). In this figure, the solid line represents the line of
identity and the dashed line represents the line of regression. The regression
line is given by rCMRGlc = 1:009 rCMRGlc + 0:007.
casionally, due to the underestimation or overestimation of the
peaks (around 15–30-s postinjection). In spite of this discrep-
ancy, the recovered input functions were in very good agreement
with the measured arterial blood samples.
Our results suggest that if the PET data are very noisy, SIME
may not be able to provide acceptable estimates of CVs (or SDs)
for the parameter estimates. The poor estimates may be caused
by using an unstable information matrix to calculate the SD of
the parameters, different orders of sensitivity functions of the
output with respect to the input function model parameters, non-
linearity of the parameter space, and the dimension of the pa-
rameter space, which is very large, as well as inherent noise in
the raw data. In this case, SIMEP should be applied to calcu-
late the parameter SDs, whereby the estimated input function
and the individual tissue TACs are used to perform parameter
estimation separately. We have demonstrated that this provides
parameter estimates and SDs, which are in good agreement with
those given by the conventional kinetic method.
Similar to the conventional compartmental model fitting
approach, we found that the poorest parameter estimates are
obtained for and CBV. This occurs particularly in low-ac-
tivity regions such as WM, where there was considerable
underestimation of and overestimation of CBV. Neverthe-
less, rCMRGlc can still be estimated very reliably with the
proposed methods, even when poor estimates were obtained
for individual microparameters (rate constants) and the peak
of the input function was not estimated accurately. This is
because the value of the macro-parameter converges rapidly
and it is insensitive to the exact fitting results of [4].
Furthermore, although it is sensitive to the total AUC covered
by the input function, it is relatively insensitive to the peak
height of the input function and, therefore, the error of the
rCMRGlc estimates was not significant [13].
It is expected that the parameter-estimation results should be-
come more reliable if the kinetics of the TACs of the selected
regions are sufficiently different. The ROIs used in each of the
studies were defined and the degree of difference was identified
a priori. We found that SIME was not able to provide reliable
parameter estimates if ROIs whose associated TACs have sim-
ilar kinetics were used in the fitting procedure due to lack of in-
dependence of measurements. In this case, where there is diffi-
culty in selecting ROIs of different kinetic behavior, some other
statistical techniques, such as cluster analysis, may be helpful
to automatically identify a finite number of TACs of different
kinetic characteristics present in the raw PET data. We are cur-
rently exploring such an approach.
The accuracy of parameter estimation did not improve no-
ticeably when more than three ROIs were used. Indeed, in some
cases, the results obtained using more than three ROIs were
poorer than those obtained using three ROIs. We believe this
is because: 1) the additional measurements do not provide ad-
ditional independent information since the ROIs have similar
kinetics and 2) the computational complexity and dimensions
of the error surface, which define the parameter set, increase
with an increasing number of ROIs. The increase in computa-
tional complexity and dimensionality of the error surface may
not possess a linear relationship with the increased amount of in-
formation provided by the additional ROIs. Thus, there appears
to be an optimum number of ROIs, which should be sufficient
to provide new information beyond which the estimation task
becomes overdetermined. We found that the optimal number of
ROIs used for parameter estimation is three, which is in agree-
ment with our results from computer simulation [9]. However,
the optimal number of ROIs used in the parameter estimation
procedure may be different for different individuals. Tissue het-
erogeneity may be another reason for the estimation results de-
teriorating as more ROIs are added. It has been reported that
biased parameter estimates are obtained when a homogeneous
tissue kinetic model (e.g., our selected model) is applied to het-
erogeneous tissue kinetics [15], [16].
When compared to the work of Takikawa et al. [7] and Eberl
et al. [8], our method has the advantage that the kinetic model
parameters and CBV and the input function can be esti-
mated simultaneously with the same number of blood samples.
In addition, both Takikawa et al. and Eberl et al. used the au-
toradiographic method to quantify rCMRGlc, and this approach
assumes certain values for the kinetic model parameters, which
may lead to errors in estimating rCMRGlc [3], [4], [17]. An-
other potential advantage of our approach is that it can be ap-
plied to other tracers, provided that the input function model
can be demonstrated to be sufficiently general.
The ideal situation would be if blood sampling could be elim-
inated totally. However, at least one, and ideally two blood sam-
ples are required to determine plasma glucose concentration for
the calculation of rCMRGlc [4]. We also found that the two
late venous blood samples generally improved the performance
of our method. Thus, it is likely that some blood samples will
always be required for the calculation of rCMRGlc with FDG
PET. Importantly, venous blood sampling is much better toler-
ated by patients, as it avoids the potential complications of ar-
terial cannulation, fewer blood samples need to be taken, and
there is reduced radiation exposure to the staff who perform the
PET scans. Our results have encouraged us to proceed to full
clinical validation of the technique.
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V. CONCLUSIONS
In this paper, we validated a technique that we proposed pre-
viously for noninvasive quantification of neurologic dynamic
FDG PET studies in humans. The method uses two late venous
blood samples, which is minimally invasive and also markedly
reduces radiation exposure to staff. We also proposed and vali-
dated a post-estimation technique, which can be applied to im-
prove estimation of parameter variance (or numerical identifi-
ability) when the raw PET data are noisy. Our results demon-
strated that the input function can be recovered accurately from
two or more ROIs and no significant difference was found be-
tween rCMRGlc estimated by our methods and the gold stan-
dard method of arterial blood sampling. The proposed methods
are expected to be applicable to other tracers used in a wide
range of kinetic PET studies.
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